Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Valeant Bends On Hospital Discounts; 'Left' Turn Ahead

Executive Summary

Valeant Pharmaceuticals International Inc. pledged to provide hospitals up to 40% in discounts on two of the company's medicines, whose controversial high prices have gotten it into hot water. Meanwhile, short-seller Andrew Left said he was now long on Valeant, while T. Rowe Price sold 90% of its shares in the Canadian drug firm.


Related Content

Generic Glumetza Scripts Lupin's Strong US Run
Regrets For Valeant's Ackman, Pearson; Big Pay For Papa
Beware The 'Pitchforks,' Pharma
Valeant: Another Fine Mess
It Was Shkreli's Show, But Pharma Was On Trial
Handling Drug Price Spikes: A Sad Place To Be
'Fraud' Accusations Vex Valeant, Slam 'Specialty' Shares





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts